Literature DB >> 36258005

Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.

Lunzhi Yuan1, Huachen Zhu2,3,4, Peiwen Chen2,3,4, Ming Zhou1, Jian Ma1, Xuan Liu1, Kun Wu1, Rirong Chen2,3,4, Qiwei Liu2,3,4, Huan Yu2,3,4, Lifeng Li2,3,4, Jia Wang2,3,4, Yali Zhang1, Shengxiang Ge1, Quan Yuan1, Qiyi Tang5, Tong Cheng6, Yi Guan7,8,9, Ningshao Xia10.   

Abstract

The new predominant circulating SARS-CoV-2 variant, Omicron, can robustly escape current vaccines and neutralizing antibodies. Although Omicron has been reported to have milder replication and disease manifestations than some earlier variants, its pathogenicity in different age groups has not been well elucidated. Here, we report that the SARS-CoV-2 Omicron BA.1 sublineage causes elevated infection and lung pathogenesis in juvenile and aged hamsters, with more body weight loss, respiratory tract viral burden, and lung injury in these hamsters than in adult hamsters. Juvenile hamsters show a reduced interferon response against Omicron BA.1 infection, whereas aged hamsters show excessive proinflammatory cytokine expression, delayed viral clearance, and aggravated lung injury. Early inhaled IFN-α2b treatment suppresses Omicron BA.1 infection and lung pathogenesis in juvenile and adult hamsters. Overall, the data suggest that the diverse patterns of the innate immune response affect the disease outcomes of Omicron BA.1 infection in different age groups.
© 2022. The Author(s).

Entities:  

Keywords:  Innate immune response; Interferon treatment; Lung pathology; SARS-CoV-2 Omicron

Year:  2022        PMID: 36258005      PMCID: PMC9579545          DOI: 10.1038/s41423-022-00923-9

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   22.096


  33 in total

1.  Covid-19: Omicron variant is linked to steep rise in hospital admissions of very young children.

Authors:  Ingrid Torjesen
Journal:  BMJ       Date:  2022-01-14

2.  SARS-CoV-2, COVID-19 and the Ageing Immune System.

Authors:  Juliet M Bartleson; Dina Radenkovic; Anthony J Covarrubias; David Furman; Daniel A Winer; Eric Verdin
Journal:  Nat Aging       Date:  2021-09-14

3.  Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021.

Authors:  Lin T Brandal; Emily MacDonald; Lamprini Veneti; Tine Ravlo; Heidi Lange; Umaer Naseer; Siri Feruglio; Karoline Bragstad; Olav Hungnes; Liz E Ødeskaug; Frode Hagen; Kristian E Hanch-Hansen; Andreas Lind; Sara Viksmoen Watle; Arne M Taxt; Mia Johansen; Line Vold; Preben Aavitsland; Karin Nygård; Elisabeth H Madslien
Journal:  Euro Surveill       Date:  2021-12

4.  Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021.

Authors:  Laura Espenhain; Tjede Funk; Maria Overvad; Sofie Marie Edslev; Jannik Fonager; Anna Cäcilia Ingham; Morten Rasmussen; Sarah Leth Madsen; Caroline Hjorth Espersen; Raphael N Sieber; Marc Stegger; Vithiagaran Gunalan; Bartlomiej Wilkowski; Nicolai Balle Larsen; Rebecca Legarth; Arieh Sierra Cohen; Finn Nielsen; Janni Uyen Hoa Lam; Kjetil Erdogan Lavik; Marianne Karakis; Katja Spiess; Ellinor Marving; Christian Nielsen; Christina Wiid Svarrer; Jonas Bybjerg-Grauholm; Stefan Schytte Olsen; Anders Jensen; Tyra Grove Krause; Luise Müller
Journal:  Euro Surveill       Date:  2021-12

5.  Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19.

Authors:  Lunzhi Yuan; Huachen Zhu; Ming Zhou; Jian Ma; Rirong Chen; Liuqin Yu; Wenjia Chen; Wenshan Hong; Jia Wang; Yao Chen; Kun Wu; Wangheng Hou; Yali Zhang; Shengxiang Ge; Yixin Chen; Quan Yuan; Qiyi Tang; Tong Cheng; Yi Guan; Ningshao Xia
Journal:  Protein Cell       Date:  2021-09-07       Impact factor: 14.870

6.  SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-12-17       Impact factor: 17.586

7.  A human circulating immune cell landscape in aging and COVID-19.

Authors:  Yingfeng Zheng; Xiuxing Liu; Wenqing Le; Lihui Xie; He Li; Wen Wen; Si Wang; Hongyang Wang; Guang-Hui Liu; Shuai Ma; Zhaohao Huang; Jinguo Ye; Wen Shi; Yanxia Ye; Zunpeng Liu; Moshi Song; Weiqi Zhang; Jing-Dong J Han; Juan Carlos Izpisua Belmonte; Chuanle Xiao; Jing Qu; Wenru Su
Journal:  Protein Cell       Date:  2020-08-11       Impact factor: 14.870

8.  SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.

Authors:  Hanjun Zhao; Lu Lu; Zheng Peng; Lin-Lei Chen; Xinjin Meng; Chuyuan Zhang; Jonathan Daniel Ip; Wan-Mui Chan; Allen Wing-Ho Chu; Kwok-Hung Chan; Dong-Yan Jin; Honglin Chen; Kwok-Yung Yuen; Kelvin Kai-Wang To
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

9.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.

Authors:  Raquel Viana; Sikhulile Moyo; Daniel G Amoako; Houriiyah Tegally; Cathrine Scheepers; Christian L Althaus; Ugochukwu J Anyaneji; Phillip A Bester; Maciej F Boni; Mohammed Chand; Wonderful T Choga; Rachel Colquhoun; Michaela Davids; Koen Deforche; Deelan Doolabh; Louis du Plessis; Susan Engelbrecht; Josie Everatt; Jennifer Giandhari; Marta Giovanetti; Diana Hardie; Verity Hill; Nei-Yuan Hsiao; Arash Iranzadeh; Arshad Ismail; Charity Joseph; Rageema Joseph; Legodile Koopile; Sergei L Kosakovsky Pond; Moritz U G Kraemer; Lesego Kuate-Lere; Oluwakemi Laguda-Akingba; Onalethatha Lesetedi-Mafoko; Richard J Lessells; Shahin Lockman; Alexander G Lucaci; Arisha Maharaj; Boitshoko Mahlangu; Tongai Maponga; Kamela Mahlakwane; Zinhle Makatini; Gert Marais; Dorcas Maruapula; Kereng Masupu; Mogomotsi Matshaba; Simnikiwe Mayaphi; Nokuzola Mbhele; Mpaphi B Mbulawa; Adriano Mendes; Koleka Mlisana; Anele Mnguni; Thabo Mohale; Monika Moir; Kgomotso Moruisi; Mosepele Mosepele; Gerald Motsatsi; Modisa S Motswaledi; Thongbotho Mphoyakgosi; Nokukhanya Msomi; Peter N Mwangi; Yeshnee Naidoo; Noxolo Ntuli; Martin Nyaga; Lucier Olubayo; Sureshnee Pillay; Botshelo Radibe; Yajna Ramphal; Upasana Ramphal; James E San; Lesley Scott; Roger Shapiro; Lavanya Singh; Pamela Smith-Lawrence; Wendy Stevens; Amy Strydom; Kathleen Subramoney; Naume Tebeila; Derek Tshiabuila; Joseph Tsui; Stephanie van Wyk; Steven Weaver; Constantinos K Wibmer; Eduan Wilkinson; Nicole Wolter; Alexander E Zarebski; Boitumelo Zuze; Dominique Goedhals; Wolfgang Preiser; Florette Treurnicht; Marietje Venter; Carolyn Williamson; Oliver G Pybus; Jinal Bhiman; Allison Glass; Darren P Martin; Andrew Rambaut; Simani Gaseitsiwe; Anne von Gottberg; Tulio de Oliveira
Journal:  Nature       Date:  2022-01-07       Impact factor: 49.962

10.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.

Authors:  Caroline Diorio; Sarah E Henrickson; Laura A Vella; Kevin O McNerney; Julie Chase; Chakkapong Burudpakdee; Jessica H Lee; Cristina Jasen; Fran Balamuth; David M Barrett; Brenda L Banwell; Kathrin M Bernt; Allison M Blatz; Kathleen Chiotos; Brian T Fisher; Julie C Fitzgerald; Jeffrey S Gerber; Kandace Gollomp; Christopher Gray; Stephan A Grupp; Rebecca M Harris; Todd J Kilbaugh; Audrey R Odom John; Michele Lambert; Emily J Liebling; Michele E Paessler; Whitney Petrosa; Charles Phillips; Anne F Reilly; Neil D Romberg; Alix Seif; Deborah A Sesok-Pizzini; Kathleen E Sullivan; Julie Vardaro; Edward M Behrens; David T Teachey; Hamid Bassiri
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.